Clinical Trials Browser

Phase 2/3 × OTHER × Neutropenia × Clear all

NCT01931592 2017-05-08

CLEAR

Phase 2/3 Terminated

Neoplasms, Neutropenia, Sepsis

NCT01523431 2017-03-30

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

Phase 2/3 Completed

Gastrointestinal

Diarrhea, Neutropenia, Colorectal Neoplasms